Clinical trials for NON RARE IN EUROPE: Alzheimer disease
89 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- ENROLLING BY INVITATIONN/ANCT07250113WeCareToFeedDysphagia to Reduce Care-partner Burden Full-scale RCTNorthwell Health · PI: Liron Sinvani, MD
- RECRUITINGNCT07457138Lombard Cohort of Brain Health ServicesUniversity of Milano Bicocca · PI: Carlo Ferrarese, MD, PhD
- RECRUITINGN/ANCT07286448Personalized Digital Training for COGnitive FITness in Mild Cognitive ImpairmentGiovanna Zamboni
- ACTIVE NOT RECRUITINGN/ANCT07479914Art of Memory for Cognitive Enhancement in the Monza Brain Health ServiceUniversity of Milano Bicocca · PI: Lucio Tremolizzo, MD, PhD
- RECRUITINGN/ANCT07212504Effect of Accelerated Neuromodulation of Anterior Cingulate Cortex to Enhance Cognition in Older Adults With Mild Memory ProblemsRotman Research Institute at Baycrest · PI: Linda Mah, MD
- ENROLLING BY INVITATIONN/ANCT07168824An Open Label Trial Evaluating the Efficacy of Lacticaseibacillus Paracasei PS23 on CognitionChi-Chang Huang · PI: Chi-Chang Huang, PhD
- ACTIVE NOT RECRUITINGN/ANCT07350226Electro-acupuncture for SCD With DepressionThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- RECRUITINGNCT07402161The Signature of Alzheimer's Disease in Subjective Cognitive DeclineIRCCS Policlinico S. Donato · PI: Salvatore Mazzeo, MD, PhD
- RECRUITINGPhase 2NCT07105709Open-label Extension Study in Participants With Early Alzheimer's DiseaseGlaxoSmithKline · PI: GSK Clinical Trials
- RECRUITINGN/ANCT06217575Brain Research Assessing Impacts of Neurophysiological Processing Speed Training in VeteransUniversity of Alabama at Birmingham
- RECRUITINGN/ANCT06862557Pulsed Electromagnetic Field Treatment With Dementia PatientsHerrick Medical LLC
- RECRUITINGEarly Phase 1NCT06002477Attentional Mechanisms in SCDVanderbilt University Medical Center · PI: Paul Newhouse, MD
- RECRUITINGNCT07041450Screening for Anti-amyloid Treatment Eligibility Using Digital Cognition and Blood-based BiomarkersMoCA Clinic and Institute · PI: Ziad Nasreddine, MD
- RECRUITINGNCT07235111Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative DiseasesOspedale Policlinico San Martino
- RECRUITINGN/ANCT07328386Effect of Cervical Lymphaticovenous and Lymph Node-to-Vein Anastomosis in Patients With Intracranial Lymphatic Circulation DisorderHong Joonpio
- RECRUITINGPhase 2NCT07392723ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older AdultsMichal Schnaider Beeri, Ph.D. · PI: Michal Beeri, PHD
- RECRUITINGN/ANCT06495190Cognition, Flavonoids, Exercise, Gut MicrobiomeAppalachian State University · PI: David C Nieman, DrPH
- ENROLLING BY INVITATIONN/ANCT06817902TMS Pilot in Early AD IIHealthPartners Institute · PI: Bhavani Kashyap, MBBS, PhD
- RECRUITINGN/ANCT06618872Incremental Diagnostic Value of Tau-PET With [18F]RO948 vs Amyloid-PET in Patients With Cognitive ImpairmentUniversity Hospital, Geneva
- RECRUITINGPHASE2, PHASE3NCT06647498A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationWashington University School of Medicine · PI: Eric M McDade, DO
- RECRUITINGPHASE2, PHASE3NCT05552157A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationWashington University School of Medicine · PI: Eric M McDade, DO
- RECRUITINGPhase 1NCT06372821A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILKUniversity College, London
- RECRUITINGN/ANCT06584110Buddy-Up Dyadic Physical Activity Program for Persons With Dementia and Family CaregiversThe University of Hong Kong
- ACTIVE NOT RECRUITINGPhase 2NCT06602258A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's DiseaseEisai Inc.
- RECRUITINGPhase 3NCT06585787A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)Karuna Therapeutics · PI: Bristol-Myers Squibb
- RECRUITINGNCT06584357Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD DementiaGAP Innovations, PBC
- RECRUITINGPhase 3NCT06534723Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)Sichuan Jishengtang Pharmaceutical Co., Ltd. · PI: Xiaochun Chen, Medical Doctor
- RECRUITINGNCT06547099Study to Understand Novel Biomarkers in Researching DementiaWashington University School of Medicine · PI: Randall Bateman, MD
- RECRUITINGNCT06508268Language, Speech and Motor Function in MCI Due to AD and Alzheimer's DiseaseHanze University of Applied Sciences Groningen
- ACTIVE NOT RECRUITINGPhase 3NCT06384573DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's DiseaseWashington University School of Medicine · PI: Randall J Bateman, MD
- RECRUITINGN/ANCT06338397Social & Affective Cognition in Alzheimer's Disease & Associated DisordersUniversity Hospital, Lille
- ACTIVE NOT RECRUITINGN/ANCT06245616Attenuation of Postprandial Inflammatory Processes in Alzheimer's Disease Patients by Consumption of Pomace OilSpanish National Research Council
- RECRUITINGN/ANCT06358404Developing a Peer Support Intervention for Depression in SCDMassachusetts General Hospital
- ACTIVE NOT RECRUITINGN/ANCT06758154Efficacy and Olfactory Network of Electro-acupuncture for Subjective Cognitive Decline: A Multicenter Randomized Controlled Trial and fMRI StudyThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- RECRUITINGPhase 2NCT06199037Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease PatientsShanghai Hengrui Pharmaceutical Co., Ltd.
- ACTIVE NOT RECRUITINGN/ANCT07165977Anti-inflammatory Probiotics in Cognitive FunctioningUniversity of Social Sciences and Humanities, Warsaw
- RECRUITINGN/ANCT06664229Development of Pressure Sensor Based Dementia and Fall Prevention Program for Older AdultsSunmi Song · PI: Junesun Kim, PT/PhD
- RECRUITINGNCT06993207HOme-based Brain Monitoring With a GARment-EEG to Study Cognitive Decline in the Aging PopulationBitbrain
- RECRUITINGN/ANCT05776641Gamma Light and Sound Stimulation to Prevent Dementia in Cognitively Normal People At Risk for Alzheimer's DiseaseMassachusetts General Hospital · PI: Diane Chan, MD PhD
- RECRUITINGN/ANCT06040905Causal Effect of Coenzyme Q10 Nutrition and Cognitive Dysfunction in the Metabolic Storm (Hyperglycemia and Sarcopenia) and Brain-derived Neurotrophic FactorChung Shan Medical University · PI: Ping-Ting Lin, Ph.D.
- ENROLLING BY INVITATIONN/ANCT07233512EFFECT OF PERIODONTAL TREATMENT ON ALZHEIMER DISEASE-ASSOCIATED OUTCOMESCentre Hospitalier Universitaire de Liege
- RECRUITINGNCT05925621Cognitive Neurology Unit Clinical RegistryBeth Israel Deaconess Medical Center
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05834296Study in Subjects With Mild-to-Moderate Alzheimer's DementiaAlzamend Neuro, Inc.
- RECRUITINGN/ANCT05877196A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness ResponsesArizona State University · PI: Fang Yu, PhD
- ENROLLING BY INVITATIONNCT05967390Localized Analysis of Normalized Distance From Scalp to Cortex and Personalized Evaluation (LANDSCAPE)Chinese University of Hong Kong · PI: Hanna LU, PhD
- RECRUITINGN/ANCT05887674Shanghai Non-pharmacological Intervention for Mild Cognitive Impairment and Mild Alzheimer's DiseaseRuijin Hospital
- RECRUITINGNCT05460143Optical Neuroimaging and CognitionUniversity of Cambridge · PI: Gemma Bale, PhD
- RECRUITINGN/ANCT05794451Developing an Artificial Intelligence System to Detect Cognitive ImpairmentUniversity of Haifa · PI: Johanna Czamanski-Cohen, PhD
- ACTIVE NOT RECRUITINGPhase 3NCT05738486A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)Eli Lilly and Company · PI: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
- RECRUITINGPhase 1NCT05469360Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease ParticipantsNovartis Pharmaceuticals · PI: Madhav Thambisetty, MD PhD
- ACTIVE NOT RECRUITINGNCT05768425DIagnostic Biomarkers and Symptoms in Patients With Alzheimer's Disease and Lewy bodY DementiaDanish Dementia Research Centre · PI: Oskar McWilliam
- ACTIVE NOT RECRUITINGNCT05464355Biomarkers Associated With Postoperative Cognitive DysfunctionUniversity of Oxford · PI: Martyn Ezra
- RECRUITINGNCT06122415The Swedish BioFINDER - Memory Clinic StudySkane University Hospital
- RECRUITINGPhase 1NCT05591027Safety and Target Engagement of Centella Asiatica in Cognitive ImpairmentOregon Health and Science University · PI: Amala Soumyanath, Ph.D
- ACTIVE NOT RECRUITINGNCT05731440Fluselenamyl - Beta Amyloid PET Imaging for Alzheimer DiseaseWashington University School of Medicine
- ACTIVE NOT RECRUITINGPhase 3NCT05470816Tranexamic Acid to Reduce Delirium After Gastrointestinal Surgery: the TRIGS-D TrialBayside Health · PI: Paul S Myles, DSci
- RECRUITINGPhase 3NCT05508789A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)Eli Lilly and Company · PI: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
- ACTIVE NOT RECRUITINGPhase 3NCT05463731A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)Eli Lilly and Company · PI: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
- ACTIVE NOT RECRUITINGNCT07051408Predictors Of Cognitive Decline Using Digital DevicesUniversity College, London · PI: Zuzana Walker, MD
- RECRUITINGN/ANCT05339438Pre-operative Mapping of the Anterior Temporal Lobe Using Functional MRI Innovative Techniques in in Drug-resistant Epileptic PatientsCentral Hospital, Nancy, France
- RECRUITINGN/ANCT05977088Prediction of Effectiveness of rTMS Application in Alzheimer's PatientsIstanbul Medipol University Hospital · PI: Lutfu Hanoglu, Prof. DR. MD
- RECRUITINGPhase 1NCT05040217A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive ImpairmentMark Tuszynski · PI: Mark Tuszynski, M.D., Ph.D.
- RECRUITINGPhase 4NCT05004987Aβ Dynamics in LLMDNYU Langone Health · PI: Nunzio Pomara, MD
- ACTIVE NOT RECRUITINGNCT05153941Diagnosis and Monitoring of Disease Progression Using Deep Neuro SignaturesAltoida · PI: Sophie Skalidi MD, PhD
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT05269394Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)Washington University School of Medicine · PI: Randall J Bateman, MD
- RECRUITINGNCT05635266Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesSanguine Biosciences · PI: Houman Hemmati, MD
- RECRUITINGNCT04579120Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)Tammie L. S. Benzinger, MD, PhD · PI: Tammie Benzinger, MD, PhD
- RECRUITINGNCT06339190Neurofilament Light Chain And Voice Acoustic Analyses In Dementia DiagnosisMonash University · PI: Prof. Amy Brodtmann, MBBS, FRACP, PhD, FANZAN
- RECRUITINGNCT04134923Imaging Biomarkers in Preclinical and Symptomatic ADTammie L. S. Benzinger, MD, PhD · PI: Tammie Benzinger, MD, PhD
- RECRUITINGN/ANCT06455163Eerder Erbij: The Path Towards Offering Timely Support for People With Dementia and Their CaregiversVU University of Amsterdam
- RECRUITINGNCT06561906Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma BiomarkersThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- RECRUITINGPhase 1NCT03809351UAB Alzheimer's Disease Center Core Cohort - Tau Imaging SubstudyUniversity of Alabama at Birmingham
- ACTIVE NOT RECRUITINGEarly Phase 1NCT03560960Multi-Center Development of a Novel Diagnostic Test for Alzheimer's DiseaseBoston University · PI: Wendy Qiu, MD PhD
- RECRUITINGNCT06120361The Swedish BioFINDER - Primary Care StudySkane University Hospital
- RECRUITINGN/ANCT03954899Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in AgingNatalie Denburg · PI: Natalie Denburg, Ph.D.
- RECRUITINGPhase 3NCT03848312Preventing Alzheimer's With Cognitive TrainingUniversity of South Florida
- RECRUITINGN/ANCT03671889ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's DiseaseInSightec
- RECRUITINGNCT05020106The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's DiseaseCapital Medical University
- RECRUITINGNCT03672266Studies of Brain and Body InteractionRutgers University
- ACTIVE NOT RECRUITINGNCT03278119Sleep Aging and Risk for Alzheimer's 2.0NYU Langone Health · PI: Ricardo Osorio, MD
- RECRUITINGNCT03507257Longitudinal Early-onset Alzheimer's Disease Study ProtocolIndiana University · PI: Liana Apostolova, MD
- RECRUITINGPhase 4NCT03082755Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's DiseaseUniversity of Texas at Austin · PI: Kathy Richards, PhD
- ACTIVE NOT RECRUITINGN/ANCT03772977The Brain Health Champion StudyBrigham and Women's Hospital · PI: Seth A Gale, MD
- RECRUITINGNCT05893524Uppsala-Dalarna Dementia and Gait ProjectDalarna University · PI: Anna Cristina Åberg, PhD
- RECRUITINGNCT03140865Wake Forest Alzheimer's Disease Clinical CoreWake Forest University Health Sciences · PI: Jeff Williamson, MD
- RECRUITINGNCT03621839New CSF Biomarkers for Alzheimer's DiseaseCentral Hospital, Nancy, France
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT01760005Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001Washington University School of Medicine · PI: Randall J Bateman, MD
- RECRUITINGNCT00869817Dominantly Inherited Alzheimer Network (DIAN)Washington University School of Medicine · PI: Eric McDade, DO
- ENROLLING BY INVITATIONPhase 4NCT00950430Imaging of Brain Amyloid Plaques in the Aging PopulationMayo Clinic · PI: Val Lowe, M.D.